Peptide Interaction Checker

Peptide interactions occur when two or more substances affect how each other is absorbed, metabolized, or processed in the body. Just like traditional pharmaceuticals, peptides can interact with medications, supplements, and other peptides in ways that may enhance, reduce, or alter their effects.

The severity of interactions ranges from negligible to life-threatening. Some combinations are not only safe but synergistic—meaning they work better together than separately. Others require medical supervision, adjusted dosing, or should be avoided entirely.

Key factors affecting interactions include:

• How substances are metabolized (liver, kidneys, GI tract)
• Receptor overlap and mechanism of action
• Changes to absorption and gastric emptying
• Effects on blood coagulation and cardiovascular function
• Hormonal and metabolic pathway interactions
• Individual health status, genetics, and comorbidities

A "stack" refers to combining multiple peptides to target synergistic benefits. Some stacks are well-researched and generally considered safe when dosed properly; others carry greater risks.

The Wolverine Stack (BPC-157 + TB-500)

This is one of the most popular recovery stacks. Both peptides promote tissue repair through different mechanisms—BPC-157 via growth factor pathways and TB-500 via actin-binding regulation. They are not known to interact negatively and may have complementary effects. Adding GHK-Cu creates a "recovery trinity" targeting collagen synthesis and cellular health.

Growth Hormone Secretagogue Stacks

CJC-1295 combined with GHRP-6 or GHRP-2 is a common protocol for synergistic GH release. These combinations are typically safe when IGF-1 levels are monitored regularly. However, stacking three or more GH secretagogues (e.g., CJC-1295, GHRP-6, and MK-677 together) increases risk of excessive GH stimulation and should only be attempted under medical supervision.

GLP-1 Agonists: The Critical Rule

Never stack multiple GLP-1 agonists (semaglutide, tirzepatide, liraglutide, retatrutide) together. These drugs work on overlapping receptors and combining them dramatically increases hypoglycemia risk, side effects, and overdose potential. If switching between GLP-1s, allow an appropriate washout period.

Visit our guide on peptide stacks for detailed protocols and dosing considerations.

Combining peptides with existing medications is common but requires careful consideration. The most important interactions to understand are:

GLP-1 Agonists and Insulin

If you are already on insulin for type 1 or type 2 diabetes, adding a GLP-1 agonist significantly increases hypoglycemia risk. GLP-1s enhance insulin secretion, so insulin doses typically need to be reduced by 20–50% under medical supervision. Blood glucose monitoring is essential.

Growth Hormone Secretagogues and Insulin

GH secretagogues increase insulin resistance as a secondary effect. If you require insulin, combining it with GH-promoting peptides may worsen glycemic control and require insulin dose increases. This requires regular monitoring.

Blood Thinners and NSAIDs with Peptides

Warfarin, heparin, and similar anticoagulants have a critical interaction with NSAIDs (ibuprofen, naproxen), increasing bleeding risk significantly. Some peptides like BPC-157 may affect coagulation, so this combination warrants extra caution. Always inform your provider about peptide use when on blood thinners.

Thyroid Medication and GLP-1s

GLP-1 agonists slow gastric emptying, potentially affecting how quickly thyroid medication (levothyroxine) is absorbed. Separate dosing by at least 4 hours and monitor thyroid function tests (TSH, free T4) closely.

Antidepressants (SSRIs) and Neuromodulating Peptides

Peptides like Selank and Semax affect serotonergic and dopaminergic pathways. Combined with SSRIs, there is theoretical risk of serotonin syndrome, though clinical evidence is limited. Monitor for symptoms like agitation, tremor, or elevated temperature.

For more details on specific medication interactions, see our GLP-1 side effects guide.

Before starting or combining peptides with medications, you should consult a healthcare provider if any of the following apply:

• You have type 1 or type 2 diabetes or take blood sugar medication
• You take blood thinners or have a bleeding disorder
• You have cardiovascular disease or take blood pressure medications
• You take psychiatric medications (SSRIs, antipsychotics, mood stabilizers)
• You have thyroid disease and take thyroid replacement
• You are pregnant, breastfeeding, or planning pregnancy
• You have kidney or liver disease
• You are over 65 or have multiple comorbidities
• You experience side effects or adverse reactions
• You are unsure about interaction severity or dosing

A knowledgeable provider—ideally one familiar with peptides and functional medicine—can assess your individual risk profile, order appropriate labs, and monitor your safety. This is especially important when combining three or more active substances.

For general peptide safety information, read our comprehensive peptide safety guide.

Explore our comprehensive library of peptide safety, efficacy, and protocol guides:

• Are Peptides Safe? — Overview of peptide safety profiles and regulatory status
• Peptide Stacks & Protocols — Detailed stacking strategies and synergistic combinations
• Peptide Side Effects — Common adverse reactions and how to manage them
• BPC-157 & TB-500 Blend Guide — Deep dive into the "Wolverine Stack"
• GLP-1 Side Effects & Safety — Semaglutide, tirzepatide, liraglutide safety and interactions
• Peptide Knowledge Quiz — Test your understanding of peptides and safety